{"id":35154,"date":"2022-10-21T12:04:21","date_gmt":"2022-10-21T04:04:21","guid":{"rendered":"http:\/\/biopioneer.com.tw\/?p=35154"},"modified":"2025-11-15T16:06:46","modified_gmt":"2025-11-15T08:06:46","slug":"laminin-925-933-%e5%b1%a4%e7%b2%98%e9%80%a3%e8%9b%8b%e7%99%bd-925-933cas110590-60-8-apexbio-%e8%b2%a8%e8%99%9fa1023","status":"publish","type":"post","link":"https:\/\/biopioneer.com.tw\/?p=35154","title":{"rendered":"Laminin (925-933) | \u5c64\u7c98\u9023\u86cb\u767d (925-933)CAS#110590-60-8 APExBIO \u8ca8\u865fA1023"},"content":{"rendered":"

\u7d30\u80de\u5916\u57fa\u8cea\u7cd6\u86cb\u767d\u7cfb\u5217\u5546\u54c1->><\/span><\/span>Laminin (925-933)<\/span><\/span><\/strong><\/p>\n

APExBIO Technology LLC \u662f\u4e00\u5bb6\u9818\u5148\u7684\u5c0f\u5206\u5b50\u6291\u5236\u5291 (Small Molecule Inhibitors)\/\u6d3b\u5316\u5291(Activators)\u3001\u5316\u5408\u7269\u5eab( Compound Libraries)\u3001\u80dc\u80bd(Peptides)\u3001\u6aa2\u6e2c\u8a66\u5291\u76d2(Assay Kits)\u3001\u87a2\u5149\u6a19\u8a18(Fluorescent Label)\u3001\u9176(Enzymes)\u3001\u4fee\u98fe\u6838\u82f7\u9178(Modified Nucleotides)\u3001mRNA \u5408\u6210\u4ee5\u53ca\u5404\u7a2e\u5206\u5b50\u751f\u7269\u5b78\u5de5\u5177\u7684\u4f9b\u61c9\u5546\u3002APExBIO\u63d0\u4f9b\u5ee3\u6cdb\u7684\u7522\u54c1\u7dda\uff0c\u6db5\u84cb 20 \u591a\u500b\u4e0d\u540c\u7684\u7814\u7a76\u9818\u57df\uff0c\u4f8b\u5982\u764c\u75c7(cancer)\u3001\u514d\u75ab\u5b78(immunology)\u3001\u795e\u7d93\u79d1\u5b78(neurosciences)\u3001\u7d30\u80de\u51cb\u4ea1(apoptosis)\u548c\u8868\u89c0\u907a\u50b3\u5b78(epigenetics)\u7b49\u3002\u516c\u53f8\u7e3d\u90e8\u4f4d\u65bc\u7f8e\u570b\u5fb7\u5dde\u4f11\u58eb\u9813USA (Houston, Texas)\uff0c\u81f4\u529b\u65bc\u670d\u52d9\u5168\u7403\u5ba2\u6236\u3002\u9ad8\u5ea6\u91cd\u8996\u7522\u54c1\u54c1\u8cea\u3002\u6240\u6709\u7522\u54c1\u5747\u9075\u5faa\u56b4\u683c\u7684\u751f\u7522\u6307\u5357\uff0c\u4e26\u9644\u6709\u5206\u6790\u8b49\u66f8\u3001HPLC\u3001\u8cea\u8b5c(Mass Spectrum)\u548cHMNR\u4ee5\u53ca\u9ad4\u5916\u9a57\u8b49(in vitro validation)\u3002 APExBIO\u7522\u54c1\u5df2\u88ab\u300aNature\u300b\u3001\u300aCell\u300b\u548c\u300aScience\u300b\u7b49\u773e\u591a\u9802\u7d1a\u540c\u884c\u8a55\u5be9\u671f\u520a\u5f15\u7528\u3002>>\u66f4\u591aAPExBio\u5546\u54c1<\/span><\/strong><\/em><\/span><\/a><\/p>\n

<\/p>\n

\u7d30\u80de\u53cd\u61c9(Cellular responses)\u7531\u8207\u7279\u5b9a\u53d7\u9ad4\u7d50\u5408\u7684\u86cb\u767d\u8cea(proteins)\u3001\u85e5\u7269(drugs)\u6216\u75c5\u539f\u9ad4(pathogens)\u89f8\u767c\u3002\u53d7\u9ad4\u4ecb\u5c0e(Receptor mediated signaling)\u7684\u4fe1\u865f\u50b3\u5c0e\u662f\u653e\u5927\u4fe1\u865f\u7684\u9176\u4fc3\u53cd\u61c9\u7d1a\u806f\u3002\u8abf\u7bc0\u53d7\u9ad4\u529f\u80fd\u7684\u6fc0\u52d5\u5291(agonists)\u548c\u62ee\u6297\u5291(antagonists)\u662f\u7814\u7a76\u548c\u91ab\u7642\u5be6\u8e10\u7684\u91cd\u8981\u5de5\u5177\u3002<\/p>\n

Laminin (925-933) | \u5c64\u7c98\u9023\u86cb\u767d (925-933)CAS#110590-60-8 APExBIO\u00a0 \u8ca8\u865fA1023<\/a>-Cancer Biology<\/span><\/p>\n

Extracellular matrix glycoprotein<\/p>\n

Laminin\u5c64\u7c98\u9023\u86cb\u767d (925-933) \u662f\u4e00\u7a2e\u80bd (Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg)\uff0c\u4f86\u6e90\u65bc\u8207\u5c64\u7c98\u9023\u86cb\u767d\u53d7\u9ad4\u7d50\u5408(laminin receptor)\u7684\u5c64\u7c98\u9023\u86cb\u767d B1 \u93c8\u7684\u6b98\u57fa 925-933\u3002Laminin\u5c64\u7c98\u9023\u86cb\u767d (925-933)\u662f\u7d30\u80de\u5916\u57fa\u8cea\u7cd6\u86cb\u767d\u5bb6\u65cf(extracellular matrix glycoproteins)\uff0c\u662f\u57fa\u5e95\u819c(basement membranes)\u7684\u4e3b\u8981\u975e\u81a0\u539f\u6210\u5206\u3002\u5b83\u5011\u6d89\u53ca\u591a\u7a2e\u751f\u7269\u5b78\u904e\u7a0b\uff0c\u5305\u62ec\u7d30\u80de\u7c98\u9644(cell adhesion)\u3001\u5206\u5316(differentiation)\u3001\u9077\u79fb(migration)\u3001\u4fe1\u865f\u50b3\u5c0e(signaling)\u3001\u795e\u7d93\u7a81\u751f\u9577(neurite outgrowth)\u548c\u8f49\u79fb(metastasis)\u3002\u5c64\u7c98\u9023\u86cb\u767d\u7531 3 \u689d\u4e0d\u540c\u7684\u93c8\u7d44\u6210\uff1a\u5c64\u7c98\u9023\u86cb\u767d \u03b1\u3001\u03b2 \u548c \u03b3\uff08\u5206\u5225\u70ba A\u3001B1 \u548c B2\uff09\u5c64\u7c98\u9023\u86cb\u767d \u03b2 1 \u93c8\u5177\u6709 7 \u500b\u7d50\u69cb\u4e0d\u540c\u7684\u7d50\u69cb\u57df\uff0c\u8207\u5176\u4ed6 \u03b2 \u93c8\u7570\u69cb\u9ad4\u5171\u4eab\u9019\u4e9b\u7d50\u69cb\u57df\u3002Laminin\u5c64\u7c98\u9023\u86cb\u767d (925-933)\uff0c\u03b21 \u5728\u5927\u591a\u6578\u7522\u751f\u57fa\u5e95\u819c(basement membranes)\u7684\u7d44\u7e54\u4e2d\u8868\u9054\uff0c\u4e26\u4e14\u662f\u69cb\u6210\u5c64\u7c98\u9023\u86cb\u767d 1 \u7684 3 \u689d\u93c8\u4e4b\u4e00\uff0c\u5c64\u7c98\u9023\u86cb\u767d 1 \u662f\u5f9e Engelbreth-Holm-Swarm (Engelbreth-Holm-Swarm , EHS) \u816b\u7624\u4e2d\u5206\u96e2\u7684\u7b2c\u4e00\u500b\u5c64\u7c98\u9023\u86cb\u767d\u3002\u78ba\u5b9a\u4e86\u53c3\u8207\u7d30\u80de\u9644\u8457(cell attachment)\u3001\u8da8\u5316\u6027(chemotaxis)\u548c\u8207\u5c64\u7c98\u9023\u86cb\u767d\u53d7\u9ad4\u7d50\u5408\u7684 \u03b2 1 \u93c8\u4e2d\u7684\u4e00\u500b\u5e8f\u5217\uff0c\u4e26\u986f\u793a\u5176\u5177\u6709\u6291\u5236\u8f49\u79fb(metastasis)\u7684\u80fd\u529b\u3002<\/p>\n

\"\"<\/p>\n

 <\/p>\n

    \n
  1. Talbert, Lance Edward. “Advancing Academics Through Laboratory and Classroom Research: Probing Biomolecular Structure with Novel Mass Spectrometry Methods and Revisiting Student Learning Tools.” UNIVERSITY OF CALIFORNIA. June 2019.<\/li>\n
  2. Lance E.Talbert, XingZhang, et al. “Synthesis of New S-S and C-C Bonds by Photoinitiated Radical Recombination Reactions in the Gas Phase.” International Journal of Mass Spectrometry. Available online 5 April 2019.<\/li>\n
  3. Talbert LE, Julian RR. “Directed-Backbone Dissociation Following Bond-Specific Carbon-Sulfur UVPD at 213 nm.” J Am Soc Mass Spectrom. 2018 Apr 5.PMID:29623659<\/a><\/li>\n<\/ol>\n

    \"\"<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
    Physical Appearance<\/td>\nA solid<\/td>\n<\/tr>\n
    Storage<\/td>\nStore at -20\u00b0C<\/td>\n<\/tr>\n
    M.Wt<\/td>\n967.06<\/td>\n<\/tr>\n
    Cas No.<\/td>\n110590-60-8<\/td>\n<\/tr>\n
    Formula<\/td>\nC40<\/sub>H62<\/sub>N12<\/sub>O14<\/sub>S<\/td>\n<\/tr>\n
    Synonyms<\/td>\nH2N-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-OH<\/td>\n<\/tr>\n
    Solubility<\/td>\n\u226515.53 mg\/mL in H2O; \u226517.77 mg\/mL in EtOH; \u226548.35 mg\/mL in DMSO<\/td>\n<\/tr>\n
    Chemical Name<\/td>\nLaminin (925-933)<\/td>\n<\/tr>\n
    SDF<\/td>\nDownload SDF<\/a><\/td>\n<\/tr>\n
    <\/td>\n<\/td>\n<\/tr>\n
    Shipping Condition<\/td>\nShip with blue ice, or upon other requests.<\/td>\n<\/tr>\n
    General tips<\/td>\nFor obtaining a higher solubility, please warm the tube at 37\u00b0C and shake it in the ultrasonic bath for a while. We do not recommend long-term storage for the solution, please use it up soon.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    <\/p>\n

    APExBIO\u53f0\u7063\u4ee3\u7406\u5546:\u00a0 <\/span><\/span><\/strong><\/span><\/a>https:\/\/www.apexbt.com\/<\/span><\/span><\/a><\/span><\/p>\n

    APExBIO\u63d0\u4f9b\u512a\u8cea\u7684\u80dc\u80bd\u548c\u751f\u7269\u5206\u6790\u8a66\u5291\uff0c\u5ee3\u6cdb\u7522\u54c1\u7dda\u5982Protease\u3001Chromatin\/Epigenetics\u8868\u89c0\u907a\u50b3\u5b78\u3001MAPK Signal\u3001DNA Damege\/DNA repair\u3001\u7d30\u80de\u51cb\u4ea1\u3001\u816b\u7624\u751f\u7269\u5b78\u3001Stem cell\u7b49\u7814\u7a76\u9818\u57df\uff0c \u9084\u63d0\u4f9b\u5b9a\u5236\u7684\u670d\u52d9\uff0c\u5305\u62ec\u591a\u80bd\u5408\u6210\uff0c\u6297\u9ad4\u7684\u751f\u7522\u548c\u6aa2\u6e2c\u7684\u767c\u5c55\u3002\u7522\u54c1\u7ddaDNA\/RNA prep kit\u3001Drug Screening panel\u3001Bioactive peptides\u3001Growth factors\u3001Biotinylation Reagents\u3001tag peptides\u3001amino Acids\u3001Growth factors\u7b49\u3002APExBIO\u7522\u54c1\u8cea\u91cf\u90fd\u4f34\u96a8\u8457\u8b49\u66f8\u7684\u5206\u6790\uff0c\u9ad8\u6548\u6db2\u76f8\u8272\u8b5c\uff0c\u8cea\u8b5c\uff0c\u548cHMNR\u6578\u64da\u3002
    \n\"\u578b\u9304\u4e0b\u8f09\"<\/a><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
    APExBIO\u7522\u54c1\u7dda<\/td>\n\u54c1\u9805<\/td>\nCAS#<\/td>\n#\u8ca8\u865f<\/td>\n<\/tr>\n
    Proteases<\/td>\nZ-VAD-FMK | CAS# 187389-52-2 APExBIO\u00a0 <\/a><\/td>\nCAS# 187389-52-2<\/td>\n\u8ca8\u865f\u00a0A1902<\/td>\n<\/tr>\n
    Proteinase K<\/td>\n\u86cb\u767d\u9176 K (Proteinase K) | CAS#39450-01-6 APExBIO\u00a0 \u8ca8\u865fK1037<\/a><\/td>\nCAS#39450-01-6<\/td>\n\u8ca8\u865fK1037<\/td>\n<\/tr>\n
    \u54c1\u9805<\/td>\nCAS#<\/td>\n#\u8ca8\u865f<\/td>\n\u61c9\u7528<\/td>\n<\/tr>\n
    Romidepsin (FK228, depsipeptide)<\/a><\/td>\n\n

    CAS#128517-07-7<\/p>\n

     <\/td>\n

    		\u8ca8\u865fA8173<\/td>\nHDAC1\/HDAC2\uff0c\u5f37\u6548\u548c\u9078\u64c7\u6027\u6291\u5236\u5291<\/td>\n<\/tr>\n
    Pirarubicin<\/a><\/td>\nCAS#72496-41-4<\/td>\n\u8ca8\u865fB2295<\/td>\n\u00a0anthracycline anti-neoplastic doxorubicin<\/td>\n<\/tr>\n
    Tunicamycin<\/a><\/td>\nCAS# 15663-27-1<\/td>\n\n

    \u8ca8\u865fA8321<\/p>\n

     <\/td>\n

    		\u9ad8\u6548\u3001\u5ee3\u8b5c\u7684\u5316\u7642\u85e5\u7269<\/td>\n<\/tr>\n
    Azithromycin<\/a><\/td>\nCAS#83905-01-5<\/td>\n\u00a0\u8ca8\u865fA2213<\/td>\nHsp90 inhibitor<\/td>\n<\/tr>\n
    Bleomycin Sulfate<\/a><\/td>\n\n

    CAS# 9041-93-4<\/p>\n

     <\/td>\n

    		\u8ca8\u865fB1398<\/td>\nAntibiotic by inhibiting protein synthesis<\/td>\n<\/tr>\n
    Nystatin (Fungicidin)<\/a><\/td>\nCAS#1400-61-9<\/td>\n\u8ca8\u865fB1993<\/td>\nantifungal antibiotic<\/td>\n<\/tr>\n
    Rapamycin<\/a><\/td>\nCAS#53123-88-9<\/td>\n\u8ca8\u865fA8167<\/td>\nOriginal antifungal antibiotic<\/td>\n<\/tr>\n
    Daptomycin<\/a><\/td>\nCAS#103060-53-3<\/td>\n\u8ca8\u865fA1206<\/td>\nCalcium-dependent antibiotic<\/td>\n<\/tr>\n
    \u54c1\u9805<\/td>\nCAS#<\/td>\n#\u8ca8\u865f<\/td>\n\u61c9\u7528<\/td>\n<\/tr>\n
    Z-VAD-FMK \u00a0<\/a><\/td>\nCAS# 187389-52-2<\/td>\n\u8ca8\u865f\u00a0A1902<\/td>\n\n

    Proteases<\/p>\n

    ICE-like proteases<\/td>\n<\/tr>\n

    TAPI-1 \u00a0<\/a><\/td>\nCAS#171235-71-5<\/td>\n\u8ca8\u865f\u00a0B4686<\/td>\n\n

    Proteases<\/p>\n

    TACE\/ADAM17 inhibitor Product Citation+3<\/td>\n<\/tr>\n

    Talabostat mesylate<\/a><\/td>\nCAS# 150080-09-4<\/td>\n\u8ca8\u865fB3941<\/td>\n\n

    Proteases<\/p>\n

    DPP4 \u4e8c\u80bd\u57fa\u80bd\u9176\u7279\u7570\u6027\u6291\u5236\u5291<\/td>\n<\/tr>\n

    Z-IETD-FMK<\/a><\/td>\nCAS# 210344-98-2<\/td>\n\u8ca8\u865fB3232<\/td>\ninhibitor of caspase 8<\/td>\n<\/tr>\n
    Cisplatin<\/td>\nCAS# 15663-27-1<\/td>\n\u8ca8\u865fA8321<\/td>\n\u9ad8\u6548\u3001\u5ee3\u8b5c\u7684\u5316\u7642\u85e5\u7269<\/td>\n<\/tr>\n
    17-DMAG (Alvespimycin) HCl<\/a><\/td>\nCAS#467214-21-7<\/td>\n\u00a0\u8ca8\u865fA2213<\/td>\nHsp90 inhibitor<\/td>\n<\/tr>\n
    CA-074 Me\u00a0<\/a><\/td>\nCAS# 147859-80-1<\/td>\n\u8ca8\u865fA8239<\/td>\nCathepsin B inhibitor<\/td>\n<\/tr>\n
    VX-765<\/a><\/td>\nCAS# 273404-37-8<\/td>\n\u8ca8\u865fA8238<\/td>\nCaspase-1 inhibitor<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    \u64da\u3002<\/p>\n

     <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
    A8301<\/td>\nGW788388<\/td>\n452342-67-5<\/td>\n98.05%<\/td>\nALK5 inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8302<\/td>\nTenovin-6<\/td>\n1011557-82-6<\/td>\n99.30%<\/td>\nSIRT inhibitor and p53 activator<\/td>\n<\/tr>\n
    A8303<\/td>\nGNF-5837<\/td>\n1033769-28-6<\/td>\n98.27%<\/td>\nPan-Trk inhibitor<\/td>\n<\/tr>\n
    A8304<\/td>\nFR 180204<\/td>\n865362-74-9<\/td>\n99.82%<\/td>\nERK inhibitor<\/td>\n<\/tr>\n
    A8306<\/td>\nMOG (35-55)<\/td>\n149635-73-4<\/td>\n97.75%<\/td>\nMinor component of CNS myelin<\/td>\n<\/tr>\n
    A8307<\/td>\nCrenolanib (CP-868596)<\/td>\n670220-88-9<\/td>\n97.42%<\/td>\nPDGFR-\u03b2 inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8308<\/td>\nPH-797804<\/td>\n586379-66-0<\/td>\n99.35%<\/td>\nP38 MAP kinase inhibitor, potent and selective<\/td>\n<\/tr>\n
    A8309<\/td>\nPerifosine<\/td>\n157716-52-4<\/td>\n98.00%<\/td>\nAkt inhibitor<\/td>\n<\/tr>\n
    A8310<\/td>\nPF-562271<\/td>\n717907-75-0<\/td>\n97.85%<\/td>\nATP-competitive FAK inhibitor, reversible<\/td>\n<\/tr>\n
    A8311<\/td>\nMaraviroc<\/td>\n376348-65-1<\/td>\n98.91%<\/td>\nSelective CCR5 antagonist,antiretroviral agent<\/td>\n<\/tr>\n
    A8312<\/td>\nTorin 1<\/td>\n1222998-36-8<\/td>\n99.29%<\/td>\nMTOR inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8313<\/td>\nRAF265<\/td>\n927880-90-8<\/td>\n99.24%<\/td>\nMultiple intracellular kinases inhibitor<\/td>\n<\/tr>\n
    A8314<\/td>\nTemsirolimus<\/td>\n162635-04-3<\/td>\n98.00%<\/td>\nMTOR inhibitor<\/td>\n<\/tr>\n
    A8315<\/td>\nNU7441 (KU-57788)<\/td>\n503468-95-9<\/td>\n99.09%<\/td>\nDNA-PK inhibitor<\/td>\n<\/tr>\n
    A8316<\/td>\nPD 0332991 (Palbociclib) HCl<\/td>\n827022-32-2<\/td>\n99.82%<\/td>\nCDK4\/6 inhibitor,highly selective<\/td>\n<\/tr>\n
    A8317<\/td>\nFludarabine Phosphate (Fludara)<\/td>\n75607-67-9<\/td>\n99.88%<\/td>\nInhibits STAT1 activation and DNA synthesis<\/td>\n<\/tr>\n
    A8318<\/td>\nPP242<\/td>\n1092351-67-1<\/td>\n99.30%<\/td>\nMTOR inhibitor, selective and ATP-competitive<\/td>\n<\/tr>\n
    A8319<\/td>\nDacomitinib (PF299804, PF299)<\/td>\n1110813-31-4<\/td>\n99.87%<\/td>\nHER inhibitor<\/td>\n<\/tr>\n
    A8320<\/td>\nPF-00562271<\/td>\n939791-38-5<\/td>\n98.26%<\/td>\nFAK\/Pyk2 inhibitor,potent and ATP-competitive<\/td>\n<\/tr>\n
    A8321<\/td>\nCisplatin<\/td>\n15663-27-1<\/td>\n98.00%<\/td>\nInhibits DNA synthesis,chemotherapy drug<\/td>\n<\/tr>\n
    A8322<\/td>\nNeratinib (HKI-272)<\/td>\n698387-09-6<\/td>\n99.81%<\/td>\nHER2\/EGFR inhibitor,potent and irreversible<\/td>\n<\/tr>\n
    A8323<\/td>\nWP1130<\/td>\n856243-80-6<\/td>\n99.20%<\/td>\nDeubiquitinase (DUB) inhibitor, Cell permeable<\/td>\n<\/tr>\n
    A8324<\/td>\nLDN-193189<\/td>\n1062368-24-4<\/td>\n98.98%<\/td>\nALK inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8325<\/td>\nTivantinib (ARQ 197)<\/td>\n905854-02-6<\/td>\n99.22%<\/td>\nC-Met inhibitor,non-ATP-competitive<\/td>\n<\/tr>\n
    A8326<\/td>\nAZD-5438<\/td>\n602306-29-6<\/td>\n98.56%<\/td>\nPotent CDK1\/2\/9 inhibitor<\/td>\n<\/tr>\n
    A8327<\/td>\nVerteporfin<\/td>\n129497-78-5<\/td>\n96.47%<\/td>\nPhotosensitizer used in photodynamic therapy<\/td>\n<\/tr>\n
    A8328<\/td>\nLDK378<\/td>\n1032900-25-6<\/td>\n99.73%<\/td>\nPotent ALK inhibitor<\/td>\n<\/tr>\n
    A8329<\/td>\nR428<\/td>\n1037624-75-1<\/td>\n98.06%<\/td>\nSelective Axl inhibitor<\/td>\n<\/tr>\n
    A8330<\/td>\nCX-4945 (Silmitasertib)<\/td>\n1009820-21-6<\/td>\n98.21%<\/td>\nCK2 inhibitor<\/td>\n<\/tr>\n
    A8331<\/td>\nBleomycin Sulfate<\/td>\n9041-93-4<\/td>\n99.48%<\/td>\nChemotherapy agent, induces DNA strand break<\/td>\n<\/tr>\n
    A8332<\/td>\nR788 disodium<\/td>\n1025687-58-4<\/td>\n99.73%<\/td>\nSyk inhibitor,ATP competitive and potent<\/td>\n<\/tr>\n
    A8333<\/td>\nCanagliflozin<\/td>\n842133-18-0<\/td>\n99.12%<\/td>\nSGLT2 inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8334<\/td>\nLinsitinib<\/td>\n867160-71-2<\/td>\n98.78%<\/td>\nIGF1R\/IR inhibitor,potent and novel<\/td>\n<\/tr>\n
    A8335<\/td>\nPalbociclib (PD0332991) Isethionate<\/td>\n827022-33-3<\/td>\n99.74%<\/td>\nCDK4\/6 inhibitor,highly selective<\/td>\n<\/tr>\n
    A8336<\/td>\nKU-60019<\/td>\n925701-49-1<\/td>\n98.03%<\/td>\nATM kinase inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8337<\/td>\nCX-5461<\/td>\n1138549-36-6<\/td>\n99.52%<\/td>\nPol I-mediated rRNA synthesis inhibitor<\/td>\n<\/tr>\n
    A8338<\/td>\nNSC 74859<\/td>\n501919-59-1<\/td>\n99.16%<\/td>\nStat3 inhibitor<\/td>\n<\/tr>\n
    A8339<\/td>\nTAK-875<\/td>\n1000413-72-8<\/td>\n99.71%<\/td>\nGPR40 agonist<\/td>\n<\/tr>\n
    A8340<\/td>\nCyclopamine<\/td>\n4449-51-8<\/td>\n98.19%<\/td>\nHedgehog (Hh) signaling Inhibitor<\/td>\n<\/tr>\n
    A8341<\/td>\nGo 6976<\/td>\n136194-77-9<\/td>\n99.75%<\/td>\nPKC\u03b1\/PKC\u03b21 inhibitor<\/td>\n<\/tr>\n
    A8342<\/td>\nGF 109203X<\/td>\n133052-90-1<\/td>\n98.28%<\/td>\nProtein kinase C,MLCK,PKG and PKA inhibitor<\/td>\n<\/tr>\n
    A8343<\/td>\nGo 6983<\/td>\n133053-19-7<\/td>\n97.56%<\/td>\npan-PKC inhibitor<\/td>\n<\/tr>\n
    A8344<\/td>\nK-252c<\/td>\n85753-43-1<\/td>\n98.33%<\/td>\nProtein kinase inhibitor<\/td>\n<\/tr>\n
    A8345<\/td>\nPF-562271 HCl<\/td>\n939791-41-0<\/td>\n98.50%<\/td>\nFAK\/Pyk2 inhibitor<\/td>\n<\/tr>\n
    A8346<\/td>\nBYL-719<\/td>\n1217486-61-7<\/td>\n99.89%<\/td>\nSelective PI3K\u03b1 inhibitor<\/td>\n<\/tr>\n
    A8347<\/td>\nPazopanib Hydrochloride<\/td>\n635702-64-6<\/td>\n98.55%<\/td>\nVEGFR\/PDGFR\/FGFR\/c-Kit\/ c-Fms inhibitor<\/td>\n<\/tr>\n
    A8348<\/td>\nLY2157299<\/td>\n700874-72-2<\/td>\n99.58%<\/td>\nTGF-\u03b2R1 inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8349<\/td>\nOmecamtiv mecarbil<\/td>\n873697-71-3<\/td>\n98.00%<\/td>\nCardiac myosin activator<\/td>\n<\/tr>\n
    A8350<\/td>\nAZD4547<\/td>\n1035270-39-3<\/td>\n98.72%<\/td>\nFGFR inhibitor<\/td>\n<\/tr>\n
    A8351<\/td>\nVX-809<\/td>\n936727-05-8<\/td>\n99.65%<\/td>\nCFTR corrector<\/td>\n<\/tr>\n
    A8353<\/td>\n3-Methyladenine<\/td>\n5142-23-4<\/td>\n99.69%<\/td>\nClass III PI3K inhibitor<\/td>\n<\/tr>\n
    A8354<\/td>\nA66<\/td>\n1166227-08-2<\/td>\n98.73%<\/td>\nP110\u03b1 inhibitor<\/td>\n<\/tr>\n
    A8355<\/td>\nAcetarsone<\/td>\n97-44-9<\/td>\n98.00%<\/td>\nAn organoarsenic compound<\/td>\n<\/tr>\n
    A8356<\/td>\nAcetylcysteine<\/td>\n616-91-1<\/td>\n99.25%<\/td>\nAntioxidant;mucolytic agent<\/td>\n<\/tr>\n
    A8357<\/td>\nAG-1478<\/td>\n153436-53-4<\/td>\n99.53%<\/td>\nEGFR inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8358<\/td>\nAlbendazole<\/td>\n54965-21-8<\/td>\n96.80%<\/td>\ntreatment of a variety of parasitic worm infestations<\/td>\n<\/tr>\n
    A8359<\/td>\nAlendronate sodium<\/td>\n129318-43-0<\/td>\n98.00%<\/td>\nOsteoclast-mediated bone resorption inhibitor<\/td>\n<\/tr>\n
    A8360<\/td>\nAllopurinol<\/td>\n315-30-0<\/td>\n98.48%<\/td>\nXanthine oxidase inhibitor<\/td>\n<\/tr>\n
    A8361<\/td>\nAMG-458<\/td>\n913376-83-7<\/td>\n98.00%<\/td>\nPotent c-Met inhibitor<\/td>\n<\/tr>\n
    A8362<\/td>\nArbidol HCl<\/td>\n131707-23-8<\/td>\n99.51%<\/td>\nAntiviral chemical agent<\/td>\n<\/tr>\n
    A8363<\/td>\nArgatroban<\/td>\n74863-84-6<\/td>\n99.79%<\/td>\nThrombin mediated fibrinogen cleavage inhibitor<\/td>\n<\/tr>\n
    A8364<\/td>\nARN-509<\/td>\n956104-40-8<\/td>\n99.57%<\/td>\nAndrogen receptor inhibitor<\/td>\n<\/tr>\n
    A8365<\/td>\nVarlitinib (ARRY334543)<\/td>\n845272-21-1<\/td>\n98.00%<\/td>\nErbB inhibitor<\/td>\n<\/tr>\n
    A8366<\/td>\nARRY-380<\/td>\n937265-83-3<\/td>\n98.78%<\/td>\nTyrosine kinase HER2 and p95-HER2 inhibitor<\/td>\n<\/tr>\n
    A8367<\/td>\nAST-1306<\/td>\n897383-62-9<\/td>\n98.00%<\/td>\nEGFR\/HER2 inhibitor<\/td>\n<\/tr>\n
    A8369<\/td>\nAtropine sulfate monohydrate<\/td>\n5908-99-6<\/td>\n99.44%<\/td>\nMAChRs antagonist<\/td>\n<\/tr>\n
    A8370<\/td>\nAxitinib (AG 013736)<\/td>\n319460-85-0<\/td>\n99.65%<\/td>\nVEGFR1\/ c-Kit inhibitor<\/td>\n<\/tr>\n
    A8371<\/td>\nAZ 628<\/td>\n878739-06-1<\/td>\n98.00%<\/td>\nRaf kinases,potent and ATP-competitive<\/td>\n<\/tr>\n
    A8372<\/td>\nAZ3146<\/td>\n1124329-14-1<\/td>\n98.00%<\/td>\nMps1 inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8373<\/td>\nAZD2014<\/td>\n1009298-59-2<\/td>\n98.07%<\/td>\nNovel mTOR inhibitor<\/td>\n<\/tr>\n
    A8374<\/td>\nAZD8330<\/td>\n869357-68-6<\/td>\n99.09%<\/td>\nMEK 1\/2 inhibitor<\/td>\n<\/tr>\n
    A8375<\/td>\nAZD8931 (Sapitinib)<\/td>\n848942-61-0<\/td>\n99.46%<\/td>\nErbB inhibitor<\/td>\n<\/tr>\n
    A8376<\/td>\nBephenium Hydroxynaphthoate<\/td>\n3818-50-6<\/td>\n99.79%<\/td>\nAnthelmintic agent<\/td>\n<\/tr>\n
    A8377<\/td>\nBetacarotene<\/td>\n7235-40-7<\/td>\n98.00%<\/td>\nRed-orange pigment,carotenoid<\/td>\n<\/tr>\n
    A8378<\/td>\nBetamethasone Dipropionate<\/td>\n5593-20-4<\/td>\n98.51%<\/td>\nGlucocorticoid receptor agonist<\/td>\n<\/tr>\n
    A8379<\/td>\nBetamethasone Valerate<\/td>\n2152-44-5<\/td>\n99.38%<\/td>\nanti-inflammatory corticosteroid<\/td>\n<\/tr>\n
    A8380<\/td>\nBexarotene<\/td>\n153559-49-0<\/td>\n99.91%<\/td>\nRetinoid Receptor agonist<\/td>\n<\/tr>\n
    A8381<\/td>\nBIBR-1048<\/td>\n211915-06-9<\/td>\n98.11%<\/td>\nThrombin inhibitor<\/td>\n<\/tr>\n
    A8382<\/td>\nBismuth Subsalicylate<\/td>\n14882-18-9<\/td>\n99.72%<\/td>\nProstaglandin G\/H Synthase 1\/2 inhibitor<\/td>\n<\/tr>\n
    A8384<\/td>\nBlonanserin<\/td>\n132810-10-7<\/td>\n98.00%<\/td>\nAtypical antipsychotic<\/td>\n<\/tr>\n
    A8385<\/td>\nBMS265246<\/td>\n582315-72-8<\/td>\n98.00%<\/td>\nCDK1\/2 inhibitor,potent and selective<\/td>\n<\/tr>\n
    A8386<\/td>\nBusulfan<\/td>\n55-98-1<\/td>\n98.00%<\/td>\nDNA alkylating agent<\/td>\n<\/tr>\n
    A8387<\/td>\nCalcium Gluceptate<\/td>\n17140-60-2<\/td>\n98.00%<\/td>\nCalcium supplement<\/td>\n<\/tr>\n
    A8388<\/td>\nCarbadox<\/td>\n6804-07-5<\/td>\n98.00%<\/td>\nantibiotic<\/td>\n<\/tr>\n
    A8389<\/td>\nCarbenoxolone disodium<\/td>\n7421-40-1<\/td>\n99.85%<\/td>\n11\u03b2-HSD inhibitor<\/td>\n<\/tr>\n
    A8390<\/td>\nCasanthranol<\/td>\n8024-48-4<\/td>\n98.00%<\/td>\nMixture of anthranol glycosides<\/td>\n<\/tr>\n
    A8391<\/td>\nCefdinir<\/td>\n91832-40-5<\/td>\n99.65%<\/td>\nThird generation cephalosporin antibiotic<\/td>\n<\/tr>\n
    A8392<\/td>\nCefoperazone<\/td>\n62893-19-0<\/td>\n99.61%<\/td>\nThird-generation cephalosporin antibiotic<\/td>\n<\/tr>\n
    A8393<\/td>\nCH5424802<\/td>\n1256580-46-7<\/td>\n98.00%<\/td>\nALK inhibitor,potent and ATP-competitive<\/td>\n<\/tr>\n
    A8394<\/td>\nCHIR-124<\/td>\n405168-58-3<\/td>\n98.35%<\/td>\nChk1 inhibitor,novel and potent<\/td>\n<\/tr>\n
    A8395<\/td>\nCHIR-98014<\/td>\n252935-94-7<\/td>\n99.13%<\/td>\nGSK-3\u03b2 inhibitor,selective and ATP-competitive<\/td>\n<\/tr>\n
    A8396<\/td>\nCHIR-99021 (CT99021) HCl<\/td>\n1797989-42-4<\/td>\n98.00%<\/td>\nGSK-3\u03b1\/\u03b2 inhibitor<\/td>\n<\/tr>\n
    A8397<\/td>\nChlorothiazide<\/td>\n58-94-6<\/td>\n98.00%<\/td>\nCarbonic anhydrase inhibitor<\/td>\n<\/tr>\n
    A8398<\/td>\nChlorprothixene<\/td>\n113-59-7<\/td>\n99.59%<\/td>\nDopamine receptor antagonist<\/td>\n<\/tr>\n
    A8399<\/td>\nCiprofloxacin<\/td>\n85721-33-1<\/td>\n99.69%<\/td>\nTopoisomerase inhibitor<\/td>\n<\/tr>\n
    A8400<\/td>\nClinafloxacin CI96 AM1091<\/td>\n105956-97-6<\/td>\n98.00%<\/td>\nTopoisomerase inhibitor<\/td>\n<\/tr>\n
    A8401<\/td>\nClotrimazole<\/td>\n23593-75-1<\/td>\n98.86%<\/td>\nantifungal compound<\/td>\n<\/tr>\n
    A8402<\/td>\nConivaptan HCl<\/td>\n168626-94-6<\/td>\n99.90%<\/td>\nVasopressin receptor antagonist<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

     <\/p>\n","protected":false},"excerpt":{"rendered":"

    \u7d30\u80de\u5916\u57fa\u8cea\u7cd6\u86cb\u767d\u7cfb\u5217\u5546\u54c1->>Laminin (925-933) APExBIO Technolo […]<\/p>\n","protected":false},"author":3,"featured_media":47343,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[5368,3],"tags":[5011],"_links":{"self":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/35154"}],"collection":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=35154"}],"version-history":[{"count":8,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/35154\/revisions"}],"predecessor-version":[{"id":53788,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/35154\/revisions\/53788"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/47343"}],"wp:attachment":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=35154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=35154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=35154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}